ReviewTherapeutic advances in hematology2026

Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy.

Abdulrahman F Al-Mashdali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.